Table 4.

Results of the classification tree analysis showing the relationship between clinical characteristics and the change in the relative peak area of the N-glycan subclasses with their respective accuracy values.

Clinical Parameters	Results	Accuracy
Positive outcome of the surgery	Δ total afucosylated ≥ −21%	0.69
Have diabetes	Δ total terminal galactosylated ≥ 81.53%	0.81
Have other disease	Δ total terminal galactosylated ≥ 81.53% or Δ total terminal galactosylated < 81.53% and Δ total sialylated ≥ 9.065%	0.69
Positive outcome of the surgery and smoker	Δ neutral < −9.26%	0.63
Positive outcome of the surgery and non-smoker	Δ total sialylated < −1.05%	0.81
Negative outcome of the surgery and non-smoker	Δ total afucosylated < −21%	0.7
Negative outcome of the surgery and no COPD	Δ total afucosylated < −21%	0.69
Negative outcome of the surgery and atherosclerosis	Δ total afucosylated < −21%	0.75
Have COPD and atherosclerosis	Δ total sialylated ≥ 7.4% or Δ total sialylated < 7.4% and −5.56% ≤ Δ total afucosylated < −2.21%	0.63
Not have COPD but diabetes	Δ total afucosylated < −21%	0.75
Not have COPD and diabetes	Δ total afucosylated ≥ 4.57% or Δ total afucosylated < 1.4%	0.63
Negative outcome of the surgery and have diabetes	Δ total afucosylated < −21%	0.75
Not have diabetes but atherosclerosis	Δ total sialylated ≥ 7.41%	0.75
Not have atherosclerosis but diabetes	Δ total afucosylated < −21%	0.81
Smoker and have diabetes	Δ total afucosylated < −21%	0.81
Non-smoker and not have diabetes	Δ total afucosylated ≥ −21	0.63
Smoker and not have COPD	Δ total afucosylated < −21	0.69
Non-smoker and have atherosclerosis	Δ total sialylated ≥ 7.4% or Δ total sialylated < 7.4% and −5.56% ≤ Δ total afucosylated <−2.21%	0.63
Smoker and not have atherosclerosis	Δ total afucosylated < −21%	0.69